Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Jun 2024 for Jasper Therapeutics, Inc., €1,532. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Edwin Jonathan Tucker: trading record in brief
Edwin Jonathan Tucker (senior executive) discloses dealings in 2 companies, chiefly Mirum Pharmaceuticals, Inc. and Jasper Therapeutics, Inc. In total, 4 filings cover trades dated from 10 May 2021 to 7 June 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 10 June 2024, reports a share grant of €1,532 in Jasper Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Edwin Jonathan Tucker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
400 shares@ US$4.1735100.0% of flowVoting Common StockSEC:0001213900-24-051417:0
70 shares@ US$13.5154.4% of flowCommon StockSEC:0001209191-21-064453:0
8,125 shares0Common StockSEC:0001209191-21-058604:0
1,483 shares@ US$14.6295.6% of flowCommon StockSEC:0001209191-21-032163:0
4 of 4 declarations
